NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1

Hypertension

Volumn 45, Issue 2, 2005, Pages 283-287

  Elmarakby, Ahmed A ^a   Loomis, E Dabbs ^a   Pollock, Jennifer S ^a   Pollock, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endothelin; Oxidative stress; Sodium

Indexed keywords

APOCYNIN; DRINKING WATER; ENDOTHELIN 1; ISOPROSTANE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM; SUPEROXIDE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; ENZYME INHIBITION; HYPERTENSION; INFLAMMATION; INFUSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TELEMETRY;

ACETOPHENONES; ANIMALS; ANTIOXIDANTS; CYCLIC N-OXIDES; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIN-1; ENZYME INHIBITORS; HYPERTENSION; INFUSION PUMPS; MALE; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS; SUPEROXIDES;

EID: 13144293998     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000153051.56460.6a     Document Type: Article

References (25)

1. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
2. A receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Am J Physiol Regul Integr Comp Physiol. 1998;275:R245-R252.
3. Lariviere R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
4. Sasser JM, Pollock JS, Pollock DM. Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol. 2002; 283:R243-R248.
5. A-receptor blockade in angiotensin II-induced hypertension. Hypertension. 1997;29:435-441.
6. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, Harrison DG. Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension. 1997;30:29-34.
7. Treiber FA, Jackson RW, Davis H, Pollock JS, Kapuku G, Mensah GA, Pollock DM. Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males. Hypertension. 2000;35:722-725.
8. Ergul A. Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension. Hypertension. 2000;36: 62-67.
9. Diederich D, Skopec J, Diederich A, Dai FX. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension. 1994;23:957-961.
10. - formation. Nephrol Dial Transplant. 2000;15:339-346.
11. Wedgwood S, Dettman RW, Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1058-L1067.
12. Loomis ED, Beswick RA, Webb RC, Pollock DM, Pollock JS. Endothelin-mediated superoxide production in rat aortic rings. FASEB J. 2002;16:A430.
13. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, Granger JP. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension. 2003;42: 806-810.
14. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation. 2003;107: 1053-1058.
15. B receptor-deficient rats. J Cardiovasc Pharmacol. 2004; 44(supplement 1):S7-S10.
16. Pollock DM, Pollock JS. Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol 2001;281:F144-F150.
17. Wang Y, Wang DH. Prevention of endothelin-1-induced increases in blood pressure; role of endogenous CGRP. Am J Physiol Heart Circ Physiol. 2004;287:H1868-H1874.
18. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 2001;38:1107-1111.
19. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 2001;37: 781-786.
20. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
21. Hoagland KM, Maier KG, Roman RJ. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. Hypertension. 2003;41:697-702.
22. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64.
23. B receptor blockade in rats on a high-salt diet. Hypertension. 2004;44:770-774.
24. 2 leads to hypertension. Hypertension. 2003;42:25-30.
25. B receptors in the renal medulla. Hypertension. 2003;41:1359-1363.